PKM and cancer: Indeed, replacement of PKM2 with PKM1 in lung tumour cells correlated with impaired tumour occurrence in mouse xenografts [97]. PKM splicing in cancer cells is modulated by hnRNP A1, hnRNP A2, and hnRNP I/PTB, which cooperate to promote splicing of PKM2 by binding to sequences flanking exon 9 and repressing its inclusion [100, 101].